Jorgensen, W. L. The many roles of computation in drug discovery. Science 303, 1813–1818 (2004).
Article CAS PubMed Google Scholar
Muegge, I., Bergner, A. & Kriegl, J. M. Computer-aided drug design at Boehringer Ingelheim. J. Comput. Aided Mol. Des. 31, 275–285 (2017).
Article CAS PubMed Google Scholar
Hillisch, A., Heinrich, N. & Wild, H. Computational chemistry in the pharmaceutical industry: from childhood to adolescence. ChemMedChem 10, 1958–1962 (2015).
Article CAS PubMed Google Scholar
Bissantz, C., Kuhn, B. & Stahl, M. A medicinal chemist’s guide to molecular interactions. J. Med. Chem. 53, 5061–5084 (2010).
Article CAS PubMed PubMed Central Google Scholar
Śledź, P. & Caflisch, A. Protein structure-based drug design: from docking to molecular dynamics. Curr. Opin. Struct. Biol. 48, 93–102 (2018).
Kolb, P. & Irwin, J. J. Docking screens: right for the right reasons?. Curr. Top. Med. Chem. 9, 755–770 (2009).
Article CAS PubMed PubMed Central Google Scholar
Nada, H., Meanwell, N. A. & Gabr, M. T. Virtual screening: hope, hype, and the fine line in between. Expert Opin. Drug Discov. 20, 145–162 (2025).
Article PubMed PubMed Central Google Scholar
Kryshtafovych, A. et al. New prediction categories in CASP15. Proteins 91, 1550–1557 (2023).
Article CAS PubMed Google Scholar
Jansen, J. M., Cornell, W., Tseng, Y. J. & Amaro, R. E. Teach–Discover–Treat (TDT): collaborative computational drug discovery for neglected diseases. J. Mol. Graph. Model. 38, 360–362 (2012).
Article CAS PubMed PubMed Central Google Scholar
Wagner, J. R. et al. Continuous evaluation of ligand protein predictions: a weekly community challenge for drug docking. Structure 27, 1326–1335 (2019).
Article CAS PubMed PubMed Central Google Scholar
Gathiaka, S. et al. D3R grand challenge 2015: evaluation of protein–ligand pose and affinity predictions. J. Comput. Aided Mol. Des. 30, 651–668 (2016).
Article CAS PubMed PubMed Central Google Scholar
Gaieb, Z. et al. D3R Grand Challenge 2: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies. J. Comput. Aided Mol. Des. 32, 1–20 (2018).
Article CAS PubMed Google Scholar
Gaieb, Z. et al. D3R Grand Challenge 3: blind prediction of protein–ligand poses and affinity rankings. J. Comput. Aided Mol. Des. 33, 1–18 (2019).
Article CAS PubMed PubMed Central Google Scholar
Parks, C. D. et al. D3R Grand Challenge 4: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies. J. Comput. Aided Mol. Des. 34, 99–119 (2020).
Article CAS PubMed PubMed Central Google Scholar
Carlson, H. A. et al. CSAR 2014: a benchmark exercise using unpublished data from pharma. J. Chem. Inf. Model. 56, 1063–1077 (2016).
Article CAS PubMed PubMed Central Google Scholar
Smith, R. D. et al. CSAR benchmark exercise 2013: evaluation of results from a combined computational protein design, docking, and scoring/ranking challenge. J. Chem. Inf. Model. 56, 1022–1031 (2016).
Article CAS PubMed Google Scholar
Robin, X. et al. Assessment of protein–ligand complexes in CASP15. Proteins 91, 1811–1821 (2023).
Article CAS PubMed Google Scholar
Leemann, M. et al. Automated benchmarking of combined protein structure and ligand conformation prediction. Proteins 91, 1912–1924 (2023).
Article CAS PubMed Google Scholar
Burley, S. K. et al. Protein Data Bank (PDB): the single global macromolecular structure archive. Methods Mol. Biol. 1607, 627–641 (2017).
Article CAS PubMed PubMed Central Google Scholar
Buttenschoen, M., Morris, G. M. & Deane, C. M. PoseBusters: AI-based docking methods fail to generate physically valid poses or generalise to novel sequences. Chem. Sci. 15, 3130–3139 (2024).
Article CAS PubMed Google Scholar
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Article CAS PubMed PubMed Central Google Scholar
Krishna, R. et al. Generalized biomolecular modeling and design with RoseTTAFold All-Atom. Science 384, eadl2528 (2024).
Article CAS PubMed Google Scholar
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Article CAS PubMed PubMed Central Google Scholar
Chai Discovery Team et al. Chai-1: decoding the molecular interactions of life. Preprint at bioRxiv https://doi.org/10.1101/2024.10.10.615955 (2024).
Wohlwend, J. et al. Boltz-1: democratizing biomolecular interaction modeling. Preprint at bioRxiv https://doi.org/10.1101/2024.11.19.624167 (2024).
Passaro, S. et al. Boltz-2: towards accurate and efficient binding affinity prediction. Preprint at bioRxiv https://doi.org/10.1101/2025.06.14.659707 (2025).
ByteDance AML AI4Science Team et al. Protenix-advancing structure prediction through a comprehensive AlphaFold3 reproduction. Preprint at bioRxiv https://doi.org/10.1101/2025.01.08.631967 (2025).
Qiao, Z. et al. NeuralPLexer3: physio-realistic biomolecular complex structure prediction with flow models. Preprint at https://arxiv.org/abs/2412.10743 (2024).
Kovtun, D. et al. PINDER: the protein interaction dataset and evaluation resource. Preprint at bioRxiv https://doi.org/10.1101/2024.07.17.603980 (2024).
Durairaj, J. et al. PLINDER: the protein–ligand interactions dataset and evaluation resource. Preprint at bioRxiv https://doi.org/10.1101/2024.07.17.603955 (2024).
Malhotra, S. & Karanicolas, J. When does chemical elaboration induce a ligand to change its binding mode? J. Med. Chem. 60, 128–145 (2017).
Article CAS PubMed Google Scholar
Leung, S., Bodkin, M., Delft, F., Brennan, P. & Morris, G. SuCOS is better than RMSD for evaluating fragment elaboration and docking poses. Preprint at ChemRxiv https://doi.org/10.26434/chemrxiv.8100203.v1 (2019).
RDKit: open-source cheminformatics. https://www.rdkit.org
Studer, G. et al. A fully automated benchmarking suite to compare macromolecular complexes. Nat. Methods 23, 387–394 (2025).
Article PubMed PubMed Central Google Scholar
Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742–754 (2010).
Article CAS PubMed Google Scholar
Boby, M. L. et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science 382, eabo7201 (2023).
Article CAS PubMed PubMed Central Google Scholar
Luttens, A. et al. Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses. J. Am. Chem. Soc. 144, 2905–2920 (2022).
Comments (0)